Upregulation of Cdc2 and cyclin A during apoptosis of endothelial cells induced by cleaved high-molecular-weight kininogen.

We (8) reported that the cleaved high-molecular-weight kininogen (HKa) and its domain 5 (D5) inhibited angiogenesis. Further studies (15) revealed that D5 could inhibit cell proliferation and induce apoptosis of proliferating endothelial cells, which together may represent a critical part of antiangiogenic activity of HKa and D5. In the present study, we further examined the effect of HKa on cell cycle progression and cell viability. We report that HKa induced a significant upregulation of Cdc2 and cyclin A in proliferating endothelial cells, concurrent with a marked increase of Cdc2 activity. The increased expression of Cdc2 and cyclin A by HKa was not associated with an apparent change in cell cycle profiles of basic fibroblast growth factor-stimulated proliferating cells, but closely correlated with a marked increase of apoptosis, suggesting that the elevated Cdc2 activity is involved in HKa-induced apoptosis of proliferating endothelial cells. Our results support an emerging hypothesis that Cdc2 and cyclin A are important regulators for cell cycle as well as for apoptosis.

[1]  William Arbuthnot Sir Lane,et al.  Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth , 1997, Cell.

[2]  Yan-Lin Guo,et al.  Tumor necrosis factor-α and ceramide induce cell death through different mechanisms in rat mesangial cells. , 1999, American journal of physiology. Renal physiology.

[3]  A. Schmaier,et al.  Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes. , 1997, Blood.

[4]  P. Chadebech,et al.  Up‐regulation of cdc2 protein during paclitaxel‐induced apoptosis , 2000, International journal of cancer.

[5]  P. Opolon,et al.  Angiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[6]  L. Porter,et al.  Abundance of cyclin B1 regulates gamma-radiation-induced apoptosis. , 2000, Blood.

[7]  D. Shaw,et al.  Two‐chain high molecular weight kininogen induces endothelial cell apoptosis and inhibits angiogenesis: partial activity within domain 5 , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  D. Litchfield,et al.  Granzyme B induces apoptosis and cyclin A-associated cyclin-dependent kinase activity in all stages of the cell cycle. , 1996, Journal of immunology.

[9]  H. Wu,et al.  Suppression of angiogenesis and tumor growth by the inhibitor K1-5 generated by plasmin-mediated proteolysis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[10]  R. Colman,et al.  Inhibition of angiogenesis by antibody blocking the action of proangiogenic high‐molecular‐weight kininogen , 2003, Journal of thrombosis and haemostasis : JTH.

[11]  Maria K. Lehtinen,et al.  Cdc2 phosphorylation of BAD links the cell cycle to the cell death machinery. , 2002, Molecular cell.

[12]  Stephen S. Gisselbrecht,et al.  Activation of cyclin A-dependent protein kinases during apoptosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[13]  R. Colman,et al.  The shape of high molecular weight kininogen. Organization into structural domains, changes with activation, and interactions with prekallikrein, as determined by electron microscopy. , 1994, The Journal of biological chemistry.

[14]  R. Colman,et al.  Kininostatin, an Angiogenic Inhibitor, Inhibits Proliferation and Induces Apoptosis of Human Endothelial Cells , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[15]  M. Llinás,et al.  Kringle 5 of Plasminogen is a Novel Inhibitor of Endothelial Cell Growth* , 1997, The Journal of Biological Chemistry.

[16]  R. Schlegel,et al.  Apoptosis and the cell cycle , 1995, Journal of cellular biochemistry.

[17]  S. Kornbluth,et al.  Regulatory roles of cyclin dependent kinase phosphorylation in cell cycle control. , 1996, Current opinion in cell biology.

[18]  M. Ha,et al.  Cdc2 and Cdk2 Kinase Activated by Transforming Growth Factor-β1 Trigger Apoptosis through the Phosphorylation of Retinoblastoma Protein in FaO Hepatoma Cells* , 1999, The Journal of Biological Chemistry.

[19]  H. Thomas,et al.  Prolonged cell-cycle arrest associated with altered cdc2 kinase in monocrotaline pyrrole-treated pulmonary artery endothelial cells. , 1998, American journal of respiratory cell and molecular biology.

[20]  L. Porter,et al.  Abundance of cyclin B1 regulates γ-radiation–induced apoptosis , 2000 .

[21]  R. Schlegel,et al.  Suppression of Apoptosis by Dominant Negative Mutants of Cyclin-dependent Protein Kinases (*) , 1996, The Journal of Biological Chemistry.

[22]  G. Cohen,et al.  Cdc2 activation is not required for thymocyte apoptosis. , 1994, Biochemical and biophysical research communications.

[23]  H. Granger,et al.  The bradykinin/B1 receptor promotes angiogenesis by up‐regulation of endogenous FGF‐2 in endothelium via the nitric oxide synthase pathway , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  M. Beckner.  Factors promoting tumor angiogenesis. , 1999, Cancer investigation.

[25]  H. Joshi,et al.  Sustained Activation of p34 cdc2 Is Required for Noscapine-induced Apoptosis* , 2001, The Journal of Biological Chemistry.

[26]  R. Colman,et al.  Domain 5 of high molecular weight kininogen (kininostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesis. , 2000, Blood.

[27]  J. Folkman,et al.  The Hemostatic System as a Regulator of Angiogenesis* , 2000, The Journal of Biological Chemistry.

[28]  H. Granger,et al.  Differential contribution of bradykinin receptors in angiogenesis. , 2000, Advances in experimental medicine and biology.

[29]  R. Colman,et al.  Different mechanisms define the antiadhesive function of high molecular weight kininogen in integrin- and urokinase receptor-dependent interactions. , 2000, Blood.